Tag: heart

PhenQ 2025 OTC Fat Burner for Men: Medically accredited supplement gains national traction with expert-backed multi-action formula and user trust.

DUBAI, United Arab Emirate, July 12, 2025 (GLOBE NEWSWIRE) -- Little Pepe, the fast-growing EVM Layer 2 meme coin, has officially surpassed $5.5 million in presale, marking a significant milestone as it enters Stage 5 with tokens now priced at $0.0014.

Area 52 launches its new line of Disposable Weed Pens – backed by a 90-day 100% money back satisfaction guarantee.

Chicago, IL, July 12, 2025 (GLOBE NEWSWIRE) -- In response to the recent floods impacting communities across Texas, Dr. Anosh Ahmed, physician and founder of the Anosh Supports America First Foundation, has announced a relief initiative aimed at assisting affected families. The initiative will include direct financial assistance, support for grieving families, and home reconstruction efforts for uninsured residents

CHICAGO, July 12, 2025 (GLOBE NEWSWIRE) -- Dr. Anosh Ahmed, a respected Republican figure and founder of the Anosh Supports America First Foundation, has pledged immediate aid to families affected by the devastating floods across Texas. Demonstrating his deep commitment to American values and conservative leadership, Dr. Anosh Ahmed Foundation has announced plans to donate to relief efforts, support grieving families, and help rebuild homes for uninsured victims.

– Absence of neurotoxicity of any grade in low-volume disease to-date –

MONTREAL and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone^® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of (i) 31,500,000 of its common shares (the “Shares”), accompanying Series A common warrants (the “Series A Common Warrants”) to purchase an aggregate of 31,500,000 common shares and accompanying Series B common warrants (the “Series B Common Warrants”) to purchase an aggregate of 31,500,000 common shares , at a combined public offering price of $1.50 per share and accompanying Series A Common Warrant and Series B Common Warrant and (ii) in lieu of common shares to certain investors that so choose, pre-funded warrants to purchase 3,502,335 common shares, accompanying Series A Common Warrants to purchase an aggregate of 3,502,335 common shares and accompanying Series B Common Warrants to purchase an aggregate of 3,502,335 common shares, at a combined public offering price of $1.499 per pre-funded warrant and accompanying Series A Common Warrant and Series B Common Warrant, which represents the combined public offering price for the Shares and accompanying common warrants less the $0.001 per share exercise price for each such pre-funded warrant. The proceeds to Milestone from the Offering, before deducting underwriting commissions and offering expenses payable by Milestone, are expected to be approximately $52.5 million. The Offering is expected to close on or about July 14, 2025, subject to satisfaction of customary closing conditions.